Adam M Marcetich

Array ( [id] => 3095276 [patent_doc_number] => 05290915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-03-01 [patent_title] => 'Placenta-derived coagulation inhibitor' [patent_app_type] => 1 [patent_app_number] => 7/820004 [patent_app_country] => US [patent_app_date] => 1992-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5461 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/290/05290915.pdf [firstpage_image] =>[orig_patent_app_number] => 820004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2778415 [patent_doc_number] => 05151501 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-09-29 [patent_title] => 'Method for solubilization and naturation of somatotropins utilizing sulfolane' [patent_app_type] => 1 [patent_app_number] => 7/811494 [patent_app_country] => US [patent_app_date] => 1991-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2294 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/151/05151501.pdf [firstpage_image] =>[orig_patent_app_number] => 811494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3422616 [patent_doc_number] => 05389611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-14 [patent_title] => 'Lactoferrin hydrolyzate for use as an antibacterial agent and as a tyrosinase inhibition agent' [patent_app_type] => 1 [patent_app_number] => 7/803955 [patent_app_country] => US [patent_app_date] => 1991-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8706 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/389/05389611.pdf [firstpage_image] =>[orig_patent_app_number] => 803955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2948645 [patent_doc_number] => 05180807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-19 [patent_title] => 'C-terminal peptide or protein sequencing reagent and method' [patent_app_type] => 1 [patent_app_number] => 7/801944 [patent_app_country] => US [patent_app_date] => 1991-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3882 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/180/05180807.pdf [firstpage_image] =>[orig_patent_app_number] => 801944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3462831 [patent_doc_number] => 05391704 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-02-21 [patent_title] => 'Methods and compositions for diagnosing chronic immune thrombocytopenic purpura' [patent_app_type] => 1 [patent_app_number] => 7/803624 [patent_app_country] => US [patent_app_date] => 1991-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 13430 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/391/05391704.pdf [firstpage_image] =>[orig_patent_app_number] => 803624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2782981 [patent_doc_number] => 05164368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-17 [patent_title] => 'Treatment for osteoporosis using growth hormone releasing factor (GRF) in combination with parathyroid hormone (PTH)' [patent_app_type] => 1 [patent_app_number] => 7/787051 [patent_app_country] => US [patent_app_date] => 1991-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2847 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/164/05164368.pdf [firstpage_image] =>[orig_patent_app_number] => 787051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2787707 [patent_doc_number] => 05155213 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'Method for isolating IgAs in the feces' [patent_app_type] => 1 [patent_app_number] => 7/783198 [patent_app_country] => US [patent_app_date] => 1991-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 956 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155213.pdf [firstpage_image] =>[orig_patent_app_number] => 783198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2819692 [patent_doc_number] => 05169627 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-08 [patent_title] => 'Oral pharmaceutical composition containing a polyethylene glycol-immunoglobulin G conjugate for reconstitution of secretory immunity and method of reconstituting secretory immunity' [patent_app_type] => 1 [patent_app_number] => 7/783360 [patent_app_country] => US [patent_app_date] => 1991-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 6231 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/169/05169627.pdf [firstpage_image] =>[orig_patent_app_number] => 783360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2955879 [patent_doc_number] => 05231178 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-27 [patent_title] => 'Method for the purification of intact, correctly-folded insulin-like growth factor-1' [patent_app_type] => 1 [patent_app_number] => 7/785171 [patent_app_country] => US [patent_app_date] => 1991-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 25459 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/231/05231178.pdf [firstpage_image] =>[orig_patent_app_number] => 785171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2885567 [patent_doc_number] => 05214029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-25 [patent_title] => 'Inhibition of malignant cells having G.sub.M1 ganglo-side sites by administration of cholera toxin' [patent_app_type] => 1 [patent_app_number] => 7/767578 [patent_app_country] => US [patent_app_date] => 1991-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 3822 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/214/05214029.pdf [firstpage_image] =>[orig_patent_app_number] => 767578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2775676 [patent_doc_number] => 05132407 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-07-21 [patent_title] => 'Purified inducible nitric oxide synthase flavoprotein' [patent_app_type] => 1 [patent_app_number] => 7/765875 [patent_app_country] => US [patent_app_date] => 1991-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5552 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/132/05132407.pdf [firstpage_image] =>[orig_patent_app_number] => 765875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2915080 [patent_doc_number] => 05234684 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-10 [patent_title] => 'Method for the prevention and treatment of bovine mastitis' [patent_app_type] => 1 [patent_app_number] => 7/751181 [patent_app_country] => US [patent_app_date] => 1991-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5008 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/234/05234684.pdf [firstpage_image] =>[orig_patent_app_number] => 751181 [rel_patent_id] =>[rel_patent_doc_number] =>)